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Abstract 
DEVELOPMENT OF A CLINICAL DECISION RULE FOR SUBARACHNOID HEMORRHAGE 
HEADACHE IN THE EMERGENCY DEPARTMENT. 
Linh H Vu, Brian MacGrory, Evie G Marcolini, Christopher H Gottschalk, David M Greer. Department of Neurology, Yale 
University, School of Medicine, New Haven, CT. 
Subarachnoid hemorrhage (SAH) is a neurological emergency associated with high morbidity and mortality.  It 
has a pre-hospital mortality rate of up to 50%, and can cause severe disability or death in 40-60% of patients.  A 
prompt diagnosis is crucial for timely work-up and intervention.  It is still frequently missed, especially in alert 
patients who present with an acute headache as the only chief complaint. Acute headache is the 5th leading 
reason for Emergency Department (ED) visits.  It accounts for about 3% of all ED visits in the US. Of these, ~2% 
will be secondary to aneurysmal SAH.  
Some guidelines have emerged in recent years to help distinguish headache due to SAH from more benign 
causes. However, their generalizability is limited due to inclusion and exclusion criteria of individual studies, as 
well as unclear definitions of terminology used in criteria. This study aims to address these shortcomings by 
creating a generalizable clinical decision tool using a broader patient population, and providing clear definitions 
in a standardized questionnaire.  
In this prospective observational study, 158 patients were interviewed using a standardized 15-item 
questionnaire.  Patients eligible were alert, able to communicate and answer the questionnaires in English, and 
had a headache presentation unrelated to trauma. Data was used to identify differential features of headache 
secondary to SAH, and these features were used to create a 5-item clinical decision tool. 
A total of 583 patients were eligible.  Of those, 158 (27%) were enrolled, provided consent, and completed our 
questionnaire. Of these, 20 had SAH. After adjusting for confounders, patients with SAH were more likely to be 
≥ 50 years old, experienced the “worst headache of [their] life,” had headache onset during exertion, had peak 
intensity instantaneously (<1 second), or had associated neck stiffness/pain. We proposed two clinical decision 
tools using these 5 features, which had a sensitivity of 100%, negative predictive value of 100%, and negative 
likelihood ratio of 0, comparable to existing rules. 
Thus, our decision rules agree with existing ones and perform similarly, but they have clearer definition for 
terminology used and can be more generalizable after external validation. (Word count: 344) 
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Background 
Headache presentation in the Emergency Department 
Acute headache is a commonly encountered chief complaint in the Emergency 
Department (ED) all over the world.  From 2010 to 2013, headache or pain in the head was 
the 4th or 5th leading cause of visits to the ED (after abdominal pain, chest pain, fever, and 
cough).  It accounted for 2.9-3.2% of all ED visits in the US from 2010 to 2013.  Headache 
was the chief complaint in 3,847 visits in 2013 according to the National Hospital 
Ambulatory Medical Care Survey (NHAMCS) [1].  Across all ambulatory care settings, 
headache accounts for 1% of all visits [2].   
 
In the existing literature, headaches are often classified into primary and secondary 
headaches.  For most purposes, patients receive a diagnosis according to the headache 
phenomenon that they present with at the current visit, or one they have presented with in the 
previous year.  The International Headache Society published guidelines in 2013, named the 
International Classification of Headache Disorders, which helps define primary versus 
secondary headache disorders.  Table A and B list some primary and secondary causes of 
headache.  Primary headaches include migraine, tension-type headache, cluster headache, or 
one of the other trigeminal autonomic cephalalgias.  Secondary headaches include new 
headache that is caused by another condition [3, 4]. 
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Table A - Primary Causes of Headache [3] 
• Migraine 
• Tension-type headache 
• Trigeminal autonomic cephalalgias 
• Other primary headache disorders (e.g., new daily persistent headache…) 
 
Table B - Secondary Causes of Headache[3] 
• Headache attributed to trauma or injury to the head and/or neck 
• Headache attributed to cranial or cervical vascular disorder 
o Stroke/TIA 
o Non-traumatic intracranial hemorrhage 
o Non-traumatic acute subdural hemorrhage 
o Unruptured vascular malformation (saccular aneurysm, AVM, DAVF) 
o Cavernous angioma 
o Sturge-Weber syndrome 
o Giant cell arteritis 
o Cervical or vertebral artery dissection 
o Central venous thrombosis 
o Reversible cerebral vasoconstriction syndrome 
o Subarachnoid hemorrhage 
o Pituitary apoplexy 
o Intracranial artery dissection 
• Headache attributed to non-vascular intracranial disorder 
o Idiopathic intracranial hypertension 
o Post-dural puncture headache 
o Non-infectious inflammatory diseases (neurosarcoidosis, aseptic 
meningitis) 
o Intracranial neoplasm 
o Epileptic seizure 
• Headache attributed to a substance or its withdrawal 
• Headache attributed to infection 
o Viral meningitis or encephalitis 
o Bacterial meningitis or encephalitis 
o Intracranial fungal or parasitic infection 
o Brain abscess 
• Headache attributed to disorder of homeostasis 
• Headache or facial pain attributed to disorder of the cranium, neck, eyes, ears, nose, 
sinuses, teeth, mouth or other facial or cervical structure 
• Headache attributed to psychiatric disorder 
• Painful cranial neuropathies and other facial pains (trigeminal neuralgia, optic 
neuritis, etc.) 
TIA = transient ischemic attack; AVM = arteriovenous malformation; DAVF = dural 
arteriovenous fistula 
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In the emergency department setting where resources are strained, headaches are 
usually divided into life-threatening, deserving more attention and diagnostic work-up, 
versus more benign causes.  Life-threatening headaches are most often from secondary 
causes, both acute and chronic.  Some examples include (but are not limited to): non-
traumatic acute subdural hemorrhage, pituitary apoplexy, colloid cyst of the third ventricle, 
autonomic dysreflexia, non-traumatic subarachnoid hemorrhage, and central nervous system 
malignancy  [3].   
 
 “Red-flag” features of Life-threatening Headaches 
Nowadays, practicing physicians are more familiar with “red flag” symptoms and 
signs during the evaluation of headache [4].  For subarachnoid hemorrhage, they include but 
not limited to: sudden onset thunderclap headache, “worst headache of my life,” onset 
associated with exertion (exercise, Valsalva, sexual intercourse), nausea, vomiting, neck 
stiffness, seizures, positive family history for aneurysm or aneurysmal subarachnoid 
hemorrhage, and positive family history for polycystic kidney disease [5].  Some red flags for 
meningitis in the history include: headache, photophobia, neck stiffness, fever, vomiting, 
altered mental status, seizures, recent brain or spine surgery, rash (meningococcemia, 
especially if the patient resides in high-density places like college dorm or military units), 
immunocompromised, and intravenous drug use.  The most common presenting symptoms 
for cavernous sinus thrombosis is only a headache.  However, any of these signs and 
symptoms can also be observed in more benign causes of headache including migraine, 
tension headache, etc., which complicate the headache evaluation and decision making 
process [6]. 
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In a retrospective study of causes of sudden death associated with acute headache, 
investigation of 55 autopsied cases revealed the most commonly associated red flag 
symptoms to include: age more than 50 years, loss of consciousness and collapse, and 
worst/thunderclap character of headache [7, 8]. 
 
 
Subarachnoid Hemorrhage and Headaches 
Subarachnoid hemorrhage (SAH) is the extravasation of blood into the space between 
the arachnoid mater and the pia mater, which normally contains cerebrospinal fluid that 
surrounds the central nervous system.  It is a neurological emergency.  Nontraumatic 
subarachnoid hemorrhage is most often caused by rupture of an intracranial aneurysm 
(accounts for 80% of nontraumatic subarachnoid hemorrhage cases [9]).  There is 
considerable variation in the incidence of SAH in the world[10], from 2 per 100,000 in China 
to 22.5 per 100,000 in Finland [11]. The incidence of SAH in the US has been reported to 
range from 9.7 to 14.5 per 100,000 population [12-14]. It was shown in previous studies that 
the pooled age-adjusted incidence rate of SAH in low- to middle-income countries was 
almost double that of high-income countries [15, 16]. 
 
Upon admission to the hospital, SAH is usually classified based on its severity using 
one of multiple grading systems, namely the Glasgow Coma Scale (GCS), the Hunt & Hess 
(H&H) score, the World Federation of Neurologic Surgeons (WFNS) Grading System (Table 
C), the Ogilvy-Carter grading system, and the Fisher SAH CT grading scale. 
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Table C - Grading Scales for Subarachnoid Hemorrhage  
Grade Hunt-Hess Scale WFNS* Scale 
1 Mild headache, normal mental status, 
no cranial nerve or motor findings 
GCS† score 15, no motor deficits 
2 Severe headache, normal mental 
status, may have cranial nerve deficit 
GCS score 13-14, no motor deficits 
3 Somnolent, confused, may have 
cranial nerve or mild motor deficit 
GCS score 13-14, with motor deficits 
4 Stupor, moderate to severe motor 
deficit, may have intermittent reflex 
posturing 
GCS score 7-12, with or without motor 
deficits 
5 Coma, reflex posturing or flaccid GCS score 3-6, with or without motor 
deficits 
 
 
SAH is a serious and commonly encountered problem in the ED.  One to two in 100 
ED patients with headache is reported to have SAH [17].  Besides being a life-threatening 
neurological emergency, it also has high morbidity and mortality, with a pre-hospital 
mortality rate of 40-60% and can cause severe disability and low quality of life [18-21].  It is 
unfortunately still frequently missed due to its heterogeneous and, in some cases, seemingly 
benign presentation [22-25].  This is especially true in alert patients who present with an 
acute headache as the only complaint [26, 27].  Some important risk factors for SAH include 
cigarette smoking, hypertension, heavy alcohol use, and personal or family history of 
aneurysm, connective tissue disorder, or hemorrhagic stroke [28].  
 
Classically, SAH presents with a “thunderclap headache,” conventionally defined 
based on both severity and rapidity of progression: a sudden severe headache that peaks to 
maximum intensity in seconds to minutes [29, 30].  It can also present with or without a 
																																																						
* WFNS = World Federation of Neurosurgical Societies. 
† Glasgow Coma Scale 
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“sentinel” headache (a severe headache two weeks prior to presentation, sometimes with 
features similar to the thunderclap headache), nuchal rigidity, decreased level of 
consciousness, papilledema, retinal hemorrhage, cranial nerve palsy, hemiparesis or 
cerebellar signs.   
 
Initial work-up for SAH includes computed tomography (CT) of the brain without IV 
contrast.  Non-contrast CT has a sensitivity of 98% at 12 hours, 93% at 24 hours, 80% at 72 
hours, and only 50% at 1 week from the initial bleeding episode [4].  If CT does not show 
SAH, or the result was unequivocal but clinical suspicion remains high, cerebrospinal fluid 
(CSF) analysis is performed to evaluate for the presence of red blood cells and 
xanthochromia (from the Greek xanthos which means yellow and chroma which means color, 
where the cerebrospinal fluid obtained from lumbar puncture appears yellowish) [28].  
Xanthochromia typically does not appear until 2-4 hours after bleeding, and is detected in 70% 
of patients at 3 weeks, and in 40% of patients in 1 month from the ictus [4].  The 
combination of non-contrast CT followed by LP for the diagnosis of SAH approaches 100% 
sensitivity, positive likelihood ratio of 3.03, and negative likelihood ratio of 0 within 12 
hours of onset, which has been deemed sufficient to rule out subarachnoid hemorrhage [24].  
Subsequent imaging may include computed tomographic angiography, catheter angiography, 
and magnetic resonance angiography [28]. However, the rate of misdiagnosis is still high at 
approximately 25% of cases, ranging from 12-64% in previous reports [17, 27, 31], mostly 
because it is not yet clear which patients would require and benefit from this work-up based 
on existing clinical decision rules and guidelines. 
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Existing guidelines 
There are some published rules and guidelines that aim to help distinguish the life-
threatening conditions from benign causes, including the SNOOP mnemonic, International 
Headache Society’s International Classification of Headache Disorders, 3rd edition-beta 
(ICHD-3 beta), the Ottawa subarachnoid hemorrhage rule, and the EMERALD (Emergency 
Medicine, Registry Analysis, Learning and Diagnosis) subarachnoid hemorrhage rule. 
 
The SNOOP mnemonic was proposed to help physicians remember and identify most 
common “red flag” symptoms to distinguish all life-threatening causes from benign ones [32, 
33].  It includes: 
S: Systemic symptoms (fever, weight loss), Secondary risks (HIV, cancer) 
N: Neurologic symptoms/signs (altered consciousness, focal deficits) 
O: Onset: sudden or split-second (think subarachnoid hemorrhage) 
O: Older: new or progressive over age 50 years (think temporal arteritis) 
P: Prior history: first, newly progressive, or different from usual headache; Positional (think 
abnormal spinal fluid pressure); Papilledema (think mass lesion, increased intracranial 
pressure). 
This mnemonic provides an organized guide to first approach headaches.  However, it does 
not provide a decision guideline and has not been validated in clinical practice. 
 
The ICHD-3 (beta) [3] was established in 2013 and defined headaches in non-
traumatic subarachnoid hemorrhage as typically severe and sudden, peaking within seconds 
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(thunderclap headache), or minutes.  This headache could be the sole symptom of SAH.  The 
diagnostic criteria for non-traumatic subarachnoid hemorrhage headache include: 
A. Any new headache fulfilling criterion C 
B. Subarachnoid hemorrhage in the absence of head trauma has been diagnosed 
C. Evidence of causation demonstrated by at least two of the following: 
a. Headache has developed in close temporal relation to other symptoms 
and/or clinical signs of SAH, or has led to the diagnosis of SAH 
b. Headache has significantly improved in parallel with stabilization or 
improvement of other symptoms or clinical or radiological signs of SAH 
c. Headache has sudden or thunderclap onset 
D. Not better accounted for by another ICHD-3 diagnosis [3] 
 
Unfortunately, the ICHD-3 beta guideline is not easily adaptable in the clinical setting 
since it does not clearly state the definition used for each criterion [34, 35].  As a result, there 
have been other studies trying to create a clinical model more appropriate for the Emergency 
Department setting, including the Ottawa SAH rule and the EMERALD rule. 
 
The Ottawa SAH rule was initially proposed to include four criteria: (1) age ≥ 40 
years; (2) presence of neck pain or stiffness; (3) witnessed loss of consciousness or confusion; 
and/or (4) onset during exertion.  This rule was reported to have a sensitivity of 98.5% (95% 
CI, 94.6% - 99.6%) and a specificity of 27.6% (95% CI, 25.7% - 29.6%).  This rule was later 
modified to include two other variables: (5) “thunderclap headache” defined as instantly 
peaking pain; and (6) limited neck flexion on examination (defined as inability to touch chin 
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to chest or raise the head 8cm off the bed if supine).  This modification led to an increase of 
the rule’s sensitivity to 100% (95% CI, 97.2% - 100.0%) with a specificity of 15.3% (95% CI, 
13.8% - 16.9%) [36].  A patient with any of these six criteria should be further worked-up to 
rule out subarachnoid hemorrhage.  It was able to identify all patients with subarachnoid 
hemorrhage in the emergency department who presented with a new headache in a study 
involving 2131 patients.  With a reported negative likelihood ratio of 0.024, which translates 
to about a 42-time reduction (=1/0.024) in the likelihood of subarachnoid hemorrhage, it is 
particularly helpful to rule-out SAH [36, 37]. 
 
Some caveats in the validation of Ottawa SAH rule should be noted, especially with 
its generalizability given its very specific inclusion and exclusion criteria.  The study was 
performed and validated for adult patients 16 and older, whose chief presenting concern was 
a nontraumatic headache that reached maximum intensity within an hour, a Glasgow Coma 
Scale of 15/15, had not sustained a fall or direct head trauma in the previous 7 days, and had 
presented within 14 days of headache onset.  Patients were also excluded from the study if 
they had a history of 3 or more recurrent headaches of the same character and intensity as the 
presenting headache over a period greater than 6 months; were referred from another hospital 
with a confirmed subarachnoid hemorrhage; returned for reassessment of the same headache 
if already investigated with both CT and lumbar puncture; had new focal neurologic findings; 
or had a previous diagnosis of cerebral aneurysm, subarachnoid hemorrhage, brain neoplasm, 
or hydrocephalus [36].  As a result, it would be challenging for many patients in the 
Emergency Department who presented with headache to meet all of the original criteria (for 
instance, having GCS 15/15).  This also means that the patient must have had a thorough 
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neurological exam done to rule out any new focal neurological deficit before qualifying for 
the diagnostic rule to be used.  Or in cases of patients with a family history of aneurysm, or 
previous chronic headache, where the rule does not apply, what clinical guideline should be 
followed? An external validation study done for the Ottawa SAH rule found it to be 
applicable to only 9% of ED patients, which greatly limited its clinical impact [38]. 
 
In trying to address some of the concerns with Ottawa SAH rule, the EMERALD 
SAH rule was developed in Japan, which expanded on the existing categorical predictors and 
added some subjective data.  Their proposed two-step decision-making rule involves using 
Ottawa SAH rule as the first screening test, and EMERALD SAH rule as the second step. 
Specifically, the EMERALD SAH rule uses any of the following criteria: (1) systolic blood 
pressure > 150 mmHg; (2) diastolic blood pressure > 90 mmHg; (3) blood sugar > 115 
mg/dL; or (4) serum potassium < 3.9 mEq/L.  It was reported to have 100% sensitivity (95% 
CI, 98.6% - 100%) and specificity of 14.5% (95% CI, 12.5% - 16.9%).  This was deemed an 
improvement upon the Ottawa SAH rule result when applied to this population of patient 
with similar sensitivity of 100% but a specificity of only 8.8% (95% CI, 7.2% - 10.7%).  
EMERALD also has strict inclusion/exclusion criteria similar to previous studies.  For 
example, patients must be 15 years and older, presenting with an acute headache that must be 
within 14 days of onset.  Patients with headache related to trauma, drugs or alcohol use, 
recurrent headaches, were excluded.  Since it also has not been externally validated, its 
application is also limited. 
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Another point to be noted is that there are elements of these clinical decision rules not 
clearly specified, leaving them up to the subjective interpretation of the physicians.  For 
instant, a thunderclap headache has only been defined as peaking “instantly.” This 
instantaneity has never been clearly defined [30, 39-43].  Is it within a second, 5 seconds, 10 
seconds, a minute, or longer? Different studies have used different definitions for thunderclap 
headache, which means the same variability may exist in the clinical setting due to clinicians’ 
cognitive biases or mental models.  Because of this, as well as the relatively low risk but high 
yield of the CT imaging and lumbar puncture combination that have now become routine in 
the clinical setting in the US, the utility of these clinical decision rules have been brought 
under scrutiny in the past few years [37, 44].  However, it can be argued that if clinical 
decision rules can be more generalizable, they can still have high utility in resource-poor 
settings where CT may not be available or too expensive, and lumbar puncture may not be 
safely or routinely performed, such as in Vietnam. 
 
SAH identification in Vietnam, a resource-poor setting 
Emergency medicine is a young and under-developed field in Vietnam.  In his 2011 
address to the First Emergency Medicine (EM) Conference in Vietnam, the Deputy Minister 
of Health for Vietnam announced, for the first time, the Vietnamese government’s 
recognition of EM as a specialty [45].  The first EM residency program was also established 
that year.  Even though healthcare infrastructure and capacity – in emergency medicine as 
well as in other fields – have steadily increased since then, these efforts often concentrate in 
tertiary care centers in populated urban cities only, with very little development in rural areas 
[46].   
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This points to a migration effect for both doctors and patients that complicates the 
delivery of care.  Many doctors are attracted by the higher wages, better working conditions, 
and availability of health technologies such as radiological imaging capacity (CT, Magnetic 
Resonance Imaging).  They then seek to work in city hospitals and clinics.  From the patients’ 
perspectives, this distribution of doctors and resources means they have to leave their 
hometown and go to the city for any illnesses that may require proper work-up and treatment.  
This is a vicious cycle that increases the burden of care on the already over-taxed tertiary 
centers in over-populated center cities.  For instance, Ho Chi Minh Cancer Hospital reported 
up to 300 new diagnoses per day, and an average of greater than 2 patients per bed [47], and 
other hospitals in the city frequently observe up to 200% bed occupancy rate [48, 49].  One 
tertiary care center in Can Tho is the only ED in that region equipped to deal with emergency 
situations, serving 17 million residents in the Mekong Delta region [50].  As a matter of fact, 
occupancy of 2-4 patients per bed is not an uncommon scene in Vietnamese tertiary care 
centers (Figure 1).   
 
Figure 1 - Patient overload in tertiary centers of Vietnam, leading to the common scene of patients having to 
share hospital beds [51]. 
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In this setting where emergency medicine capacity was only recently created with the 
first generation of ED physicians still in training, and existing resources at all levels already 
stretched thin, there is more emphasis on the development of easy clinical decision tools for 
triaging patients with life-threatening headaches.  Tools that are cost-effective, concise, not 
time-consuming, standardized, with clearly defined terminology and less room for observer 
biases, would be invaluable in this situation. 
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Statement of Purpose 
Hypothesis 
To date, many clinical decision rules have been created for the purpose of identifying 
life-threatening headaches caused by nontraumatic subarachnoid hemorrhage.  However, 
these rules often suffer from lack of generalizability due to strict study inclusion and 
exclusion criteria.  They often also fail to clearly define certain terminology directly used in 
the decision rule itself.  Most notable is the variability in the definition of time to peak onset 
for a thunderclap headache. 
 
The primary purpose of this study is to identify factors that are associated with 
increased risk of subarachnoid hemorrhage in patients presenting to the Emergency 
Department with acute headache among the chief presenting concerns.  Our study population 
did not exclude those with recurrent headaches, those who were referred from another 
hospital, those who returned from worsening of headache, or those with headache onset more 
than 14 days prior to presentation.  We also provided clear definitions of terms, such as time 
to peak onset of headache to include “less than 1 second,” “less than 5 seconds,” etc.   
 
We used a 15-item questionnaire (Appendix 1) to screen all adult patients presenting 
with an acute headache to the Yale New Haven Hospital Emergency Department and 
Neurological Intensive Care Unit, then identified features in the patient’s history and 
presentation that would put them at higher risk for subarachnoid hemorrhage.  This facilitated 
identifying a model appropriate for a broader audience in the Emergency Department.  We 
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also had a chance to compare how our clinical model performed compared to existing clinical 
decision rules in the literature. 
 
We hypothesized that, with the broader inclusion criteria and clear terminology, we 
would be able to identify patients with subarachnoid hemorrhage using mainly history-
focused skills with our 15-item questionnaire.  In addition, we expect to show that our 
method can be applied more broadly but is not inferior to existing clinical rules in term of its 
ruling out power.  This can lead to earlier and/or more appropriate diagnostic steps, referral, 
and treatment for this life-threatening condition, especially in resource-poor settings. 
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Methods 
Study Design 
This was a prospective, observational study at Yale-New Haven Hospital (YNHH) 
emergency department (ED) and Neurological Intensive Care Unit (NICU).  The study was 
conducted over a 16-month period from September 2015 to December 2016.  The study was 
designed by Dr.  Brian MacGrory (BMG), Dr.  David Greer (DG), and Linh Vu (LV, medical 
student), with support from physicians and other staff at the YNHH ED and NICU.  The 
study was approved by Yale University Institutional Review Board (Yale IRB) and Yale 
Human Research Protection Program (HRPP).   
 
Study Setting and Population 
For the purpose of this study, the YNHH New Haven campus (including its ED, 
NICU, and onsite neurosurgical services) was selected as our site since it accounts for the 
majority of ED visits at YNHH.  Yale-New Haven Hospital has about 170,000 emergency 
and/or urgent care visits per year.  Of these, the Department of Emergency Medicine (DEM) 
at the New Haven campus accounts for 75% [51].   
 
Patients were eligible for the study if they fulfilled our inclusion criteria, including: 
adult patients ≥ 18 years old; presented primarily for management of headache of any 
potential cause, and/or admitted to YNHH NICU with non-traumatic subarachnoid 
hemorrhage being considered as a diagnosis, whether through YNHH ED or in transfer from 
another hospital; presenting headache was not caused by trauma; and able to understand and 
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converse fluently in English.  Patients <18 years old, unable to give a history of the onset of 
their headache for any reason (including impaired consciousness, amnesia for the event or 
impaired cognition at baseline), unable communicate fluently in English, or patients for 
whom their headache/SAH was clearly precipitated by trauma were excluded from our study.  
Eligible subjects were identified by Linh Vu in the ED, with the help from other study 
investigators and NICU fellows for the patients who presented to the NICU from outside 
hospitals. 
 
Study Protocol and Measures 
When a patient presented to YNHH ED with “headache,” “acute headache,” and 
“migraine” as one of their chief presenting concerns at any time during their ED visit, an 
automated page will be generated by the EPIC medical record system to our study 
investigators.  When a patient was admitted to YNHH NICU service with subarachnoid 
hemorrhage as a potential diagnosis, either from YNHH ED or from an outside hospital 
(OSH), the NICU fellow on-call would notify our study investigator as well.  To make sure 
we did not miss any patients using the two approaches above, we also screened the hospital’s 
patient rosters daily using EPIC filters for “subarachnoid hemorrhage,” “SAH,” “headache,” 
and all other variations, as well as the ED and NICU patient lists for potential missed cases. 
 
All patients identified by our investigators were approached within 72 hours of initial 
presentation to the emergency department or their admission to the hospital in the case of 
transfer from an OSH by one of three study investigators: BMG, DG, or LV.  The majority of 
patients were identified, interviewed, and followed-up by LV (151 out of 158 patients 
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enrolled, approximately 96%).  All patients were asked to give informed consent.  For 
patients who gave consent to be included in our study, a standardized 15-item questionnaire 
was administered.  For those who did not provide informed consent, we documented basic 
demographic details in an anonymized fashion to account for any systematic differences in 
those who consented and those who did not.  No identifying information was collected on 
those who elected not to participate in our study. 
 
Data was collected during the period of 7AM to 5PM during weekdays.  If subjects 
presented outside of this time window, on the weekend, or were discharged from the hospital 
before study investigators were able to approach them, they were contacted by telephone.  In 
these cases, informed consent was obtained, and the questionnaire was administered via 
telephone. 
 
We started the 15-item questionnaire with an open-ended question to invite patients’ 
non-biased description with: “Please tell me about your headache.” Then we asked a series of 
questions to gather information about the following characteristics of the patient’s presenting 
headache:  
1. Location of onset  
• Temples/temporal 
• Back of head/occipital 
• Side of head/parietal 
• Front of head/frontal 
• Around head/holocranial 
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• Eye 
• Ear 
• Neck 
• Jaw 
• Other (specify) 
2. Side of headache  
• Right-sided 
• Left-sided 
• Both sides 
• Varied 
3. Size of headache  
• Less than 6cm 
• More than 6cm 
4. Time of onset  
• Started how many seconds, minutes, hours, days, weeks, or months 
ago 
5. Duration of the headache  
• “How long did it last?” in minutes, hours, days, or ongoing headache) 
6. Time to peak intensity  
• Instantaneous (less than 1 second) 
• Less than 5 seconds 
• 5 to 10 seconds 
• 10 seconds to 1 minute 
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• 1 to 2 minutes 
• 2 to 10 minutes 
• 10 to 30 minutes 
• More than 30 minutes 
7. Characteristic quality of the headache  
• Throbbing/pulsing 
• Pressure 
• Achy 
• Burning 
• Tight 
• Searing 
• Dull 
• Shooting 
• Stabbing 
• Other (specify) 
8. Severity using a numeric scale out of 10 (“How bad is the pain on a scale of 0 
to 10: where 0 is no pain and 10 is the worst?”)  
• Lowest level of pain 
• Highest level of pain 
9. Severity based on level of disability  
• Normal activity 
• Slight decrease in function 
• Moderate decrease in function 
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• Severe decrease in function 
• Confined to bed 
10. Associated symptoms  
• Nausea 
• Vomiting 
• Sensitivity to light 
• Sensitivity to sounds 
• Sensitivity to odors  
• Fever 
• Increased urination 
• Sore/stiff neck 
• Ringing in the ears 
• Blurred vision 
• Anxiety 
• Irritability 
• Loss of consciousness 
• Memory problems 
• Confusion 
• Eye-tearing 
• Nasal congestion 
• Eye-redness 
• Droopy eyelid 
• Other (specify) 
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11. Preceding symptoms (“Did you have symptoms before your headache 
began?”) 
• One-sided weakness 
• General weakness 
• Speech difficulty 
• Double vision 
• Lightheadedness 
• Numbness/tingling 
• Loss of vision in one eye 
• Loss of vision on one side 
• Vertigo 
12. Possible provoking factors (“Did anything bring on your headache?”)  
• Food/beverage 
o Fasting 
o Chocolate 
o Nitrates 
o Alcoholic beverages 
• Physical exertion  
o Coughing 
o Exercise 
o Sexual intercourse 
• Medications  
o Anti-depressants 
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o Illicit drugs 
o Migraine medications 
• Others (specify) 
13. Activities that exacerbated headache  
• Lying down 
• Standing up 
• Exercise 
• None 
14. Relieving factors  
• Lying down 
• Standing 
• Hot compress 
• Cold compress 
• Dark quiet room 
• Keeping active/pacing 
• Others (specify) 
15. Presence of prior headaches  
• Quantified in how many per day/week/month/year or continuous  
• Quantified in the number of days in the last month patient experienced 
headaches or facial pain whether it be mild, moderate or severe in 
intensity) 
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• Presence of prior sentinel headache (“Have you had severe headache 
in the past two weeks?” and open-ended description of sentinel 
headache if yes).   
16. Past medical history: 
• Diabetes 
• Hypertension 
• Heart disease 
• Stroke/TIA 
• Seizures/epilepsy 
• Head injury 
• Ear, nose, and throat problems 
• Dental problems 
• Cervical neck/spine problems 
• Cancer and type of cancer 
• Kidney/renal disease 
• Brain hemorrhage 
• Others (specify)  
See Appendix 1 for a sample questionnaire. 
 
Outside of the questionnaire, we also gathered basic demographic and presentation 
data from patients’ charts, including but not limited to: age, sex, ethnicity, past medical 
history, weight, height, blood pressure on presentation, prior head imaging on file including 
CT, MRI, angiography of the head/neck, Glasgow Coma Scale (GCS) on presentation, Hunt 
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& Hess (HH) score on presentation.  During the follow-up/observation phase, patients’ 
records were reviewed on the day of their discharge from the hospital, with particular 
attention paid to those in whom the final diagnosis was nontraumatic subarachnoid 
hemorrhage.  For those with hemorrhage, we noted the Fisher imaging grade based on 
imaging at presentation, and also noted the vascular territory involved, clinical grading of 
subarachnoid hemorrhage, presence or absence of intraventricular clot, and whether or not 
the hemorrhage was aneurysmal in nature. 
 
All study data was kept in a study database.  Only the principal investigator (DG) and 
study investigators (BMG, LV) had access to this data for the duration of the study.  All 
information was de-identified at the earliest reasonable time after the data was received.  We 
replaced identifying information with a deidentified code that did not directly identify the 
subject.  Study investigator LV kept a key that linked the patient ID to the coded information.  
This link was kept separate, secure, and available only to the study team.  Any information 
that could identify study participants remained confidential and was stored in an encrypted 
form. 
 
Data Analysis 
Data analysis was performed by Linh Vu.  Patients who withdrew at any stage of the study 
were not included in the final analysis.  The headaches were characterized with descriptive 
statistics calculated for patient demographic, clinical findings, and ED diagnoses. 
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Statistical analyses were performed with Fisher’s exact test and Mann–Whitney’s unpaired t-
test.  An alpha of 5% was used as a threshold for statistical significance (two-sided).  We also 
compared proportions between groups by means of relative risks (RRs) or mean differences, 
as appropriate, with their corresponding 95% confidence intervals (95% CIs).  Linear 
regression analysis was used when the outcome variable was continuous.  Logistic regression 
analysis was used when the outcome was a binary event.  Similarly, multiple logistic 
regression analysis was used when the outcome was a binary event.  Statistical analysis was 
performed using STATA 14.1 (StataCorp) and SPSS 24.0 (SPSS, Inc.). 
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Results 
Summary statistics – Enrolled vs.  “Missed potentially eligible” 
Figure 2 - Details of enrollment and flow of patients in study.  SAH = Subarachnoid hemorrhage 
 
 
There were 583 patients with headaches who presented to the YNHH ED and/or 
NICU over a 16-month period from September 2015 to December 2016.  After applying the 
exclusion criteria, the study flow for these patients is shown in Figure 2.  Of these, we were 
able to enroll 158 patients (27% enrollment rate of eligible patients), 20 of whom had a 
diagnosis of subarachnoid hemorrhage (3% of eligible patients).  Four hundred and twenty-
five patients were not enrolled into our study, from reasons including, but not limited to: 
patient left the Emergency Department before being approached by investigators and was not 
reachable by telephone; patient transferred to another hospital before being approached by 
investigators; patient came into the Emergency Department outside of the in-person 
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screening time window and was not reachable by telephone; patient did not provide full 
informed consent; and/or the patient did not want to be involved in study (Table D).  They 
were considered to be “missed potentially eligible.” Table E shows the basic demographic 
characteristics of the 158 enrolled patients versus the 425 “missed potentially eligible 
patients.” The enrolled patients had mean age of 42 (SD 17, range 18-85), 74% of whom 
were women, 21% Hispanic, and 38% Caucasian.  The “missed potentially eligible” patients 
had mean age of 41 (SD 18, range 18-94), 66% of whom were women, 25% Hispanic, and 
38% Caucasian.  The two groups did not differ significantly in terms of age, sex, ethnicity, or 
race. 
 
Table D – Reasons for non-enrollment 
• Patient left the Emergency Department before being approached by investigators 
and was not reachable by telephone 
• Patient transferred to another hospital before being approached by investigators 
• Patient came into the Emergency Department outside of the in-person screening 
time window and was not reachable by telephone 
• Patient did not provide full informed consent 
 
 
 
 
Table E - Demographic characteristics of patients identified with a headache who were 
enrolled versus those who were not 
  
 
Enrolled (n=158) Not enrolled (n=425) p-value 
Age - Mean (SD, range) 42 (17, 18-85) 41 (18, 18-94) 0.41 
Female sex  74% 66% 0.06 
Hispanic 21% 25% 0.28 
Caucasian 38% 38% 1.00 
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Summary statistics – Basic Demographics 
Table F – Summarized demographic, presentation, and headache characteristics of enrolled 
participants (n=158) 
Characteristics Patients 
Age - Mean (SD) (range) 43 (17) (18-85) 
Age > 40 years old 84 53% 
Female sex  117 74% 
Hispanic 33 21% 
Caucasian 60 38% 
Admitted 35 22% 
Onset during exertion 22 14% 
Headache awoke patient from sleep 12 8% 
“Worst headache of my life” 21 13% 
 
Table F presents an overview of the social, demographic, health and headache 
characteristics of 158 study participants, including 20 patients (12.7%) with SAHs.  Overall, 
participants were approximately 55 years old at intake (SD = 15, range 18-84).  About half of 
the study participants were over 40 years old.  The majority were female (74%).  More than 
half of participants identified as Caucasian (38%), and 21% as Hispanics.  Headache onset 
during exertion was experienced by 22 (14%) patients.  Eleven (8%) reported they were 
awoken by a headache.  Twenty-one (13%) patients reported the presenting headache to be 
the “worst headache of my life.” Since we did not exclude patients based on headache onset, 
our study sees a wide spread of time since onset of headache: only 4 patients (3%) present to 
the ED within 1 hour of headache onset; 31 patients (20%) presented within 1 day; 23 
patients (15%) presented within 1 week; and the majority (98 patients, 63%) presented more 
than a week after the headache first started.  See Table J in Appendix 2 for details on all 
headache characteristics. 
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Regression Analysis 
Table G shows the univariate correlation of selective headache characteristics, 
stratified by a final diagnosis of SAH versus no SAH in the first 3 columns.  Overall, patients 
with SAH (n = 20) were significantly older than those without SAH (n = 138), with mean age 
of 55 versus 41, respectively (p < 0.001).  The SAH patient population was much more likely 
to be over the age of 40 (85% versus 49%, p =0.003), more likely to be Caucasian (65% 
versus 34%, p = 0.012), more likely to have headache onset during exertion (70% versus 6%, 
p <0.001), headache described as “worst headache of my life,” (85% versus 3%, p < 0.001), 
more likely to be occipital (55% versus 22%, p = 0.005) or holocranial (50% versus 25%, p = 
0.03), more likely to have stabbing quality (35% versus 5%, p <0.001), less fluctuation in 
severity throughout the course of the headache (p = 0.009), more likely to peak 
instantaneously in less than 1 second (65% versus 10%, p < 0.001) as well as in less than a 
minute (80% versus 17%, p < 0.001),  associated with neck pain or stiffness (80% versus 
42%, p = 0.002), less likely to have had prior headaches (50% versus 83%, p = 0.002), and 
less days of headache in the last month (p < 0.001). 
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Table G – Demographic and headache characteristics’ association with a diagnosis of SAH 
using regression analysis 
  SAH  
 
No SAH  
 
Univariate 
p-value 
 Correlation 
efficient (r) 
Multivariate 
(OR, 95% CI) 
No. 20 
(13%) 
138 
(87%) 
    
Age - Mean (SD)  55 (15) 41 (16) <0.001***  0.27*** 1.1 (1.00-1.16) 
Age > 40 years  85% 49% 0.003**  0.25** 11.5 (0.6-216.8) 
Age > 50 years 70% 26% <0.001***  0.31*** 27.0 (1.2-635.3)* 
Female sex 60% 76% 0.17    
Hispanic 10% 22% 0.25    
Caucasian  65% 34% 0.012*  0.24** 1.4 (0.1-13.5) 
Admitted  100% 11% <0.001***  - - 
Onset during exertion  70% 6% <0.001***  0.62*** 56.1 (3.7-
847.6)** 
Headache woke 
patient from sleep 
15% 7% 0.29  -  
“Worst headache of 
my life”  
85% 3% <0.001***  0.80*** 76.5 (6.0-982.5) 
*** 
Blood pressure on 
presentation 
      
   SBP - Mean (SD) 139 (20) 135 (22) 0.38    
   DBP - Mean (SD) 79 (15) 81 (15) 0.57    
Time since onset 
(hours) - Mean (SD) 
66 (38) 828 
(7538) 
0.24    
Location of headache          
   Temporal 10% 15% 0.74    
   Occipital  55% 22% 0.005**  0.24** - 
   Frontal 35% 28% 0.60    
   Holocranial  50% 25% 0.03*  0.18* - 
   Other 10% 9% 1.00    
Headache quality          
   Throbbing/Pulsing 60% 45% 0.24    
   Pressure 30% 49% 0.15    
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Table G – Demographic and headache characteristics’ association with a diagnosis of SAH 
using regression analysis 
  SAH  
 
No SAH  
 
Univariate 
p-value 
 Correlation 
efficient (r) 
Multivariate 
(OR, 95% CI) 
   Burning 20% 10% 0.25    
   Shooting 15% 7% 0.18    
   Stabbing  35% 5% <0.001***  0.35*** - 
Severity of headache 
(0-10) 
         
   Range (max - min) 1 (2) 3 (3) 0.009**  - - 
Duration (hours) – 
Mean (SD) 
135 
(232) 
230 
(600) 
0.26    
Presence of prior 
headaches  
50% 83% 0.002**  -0.27** - 
# of days of headache 
in past 1 month  
2 (2) 10 (11) <0.001***  -0.24*** - 
“Sentinel headache” 
in last 2 weeks 
17% 17% 1.00    
Thunderclap 
headache (peak < 1 
minute)  
80% 17% <0.001***  0.49*** - 
Time to peak intensity        
   Instantaneously (<1 
second) 
65% 10% <0.001***  0.48*** 11.7 (1.01-
142.9)* 
   Less than 5 seconds 10% 2% 0.08    
Associated symptoms          
   Nausea 75% 54% 0.09    
   Vomiting 40% 21% 0.09    
   Photophobia 60% 59% 1.00    
   Phonophobia 40% 35% 0.63    
   Fever 5% 12% 0.70    
   Meningismus 80% 42% 0.002**  0.25** 24.4 (1.01-
591.6)* 
   LOC or confusion 20% 22% 1.00    
LOC = Loss of consciousness 
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Based on the correlation efficient listed in Table G, a multivariate logistic regression 
model was created to adjust for potential confounders.  The resultant odd ratios (ORs) for 
variables included in this model is reported in the last column of Table G.  Most notably, the 
variables having a statistically significant effect that was robust to adjustments included more 
likely to be older than 50 years (OR 20.5, p = 0.03), headache onset during exertion (OR 56.1, 
p = 0.004), being described as the “worst headache of my life,” (OR 76.5, p = 0.001), neck 
pain or stiffness (OR 24.4, p = 0.05), and time to peak intensity of less than 1 second (OR 
11.7, p = 0.05).  On the other hand, some variables such as occipital and holocranial location 
of headache, stabbing quality, presence of prior headaches, number of days of headache in 
the last month, presence of thunderclap headache (defined as peaking in less an a minute), 
being admitted to the hospital were not included in this model due to too small number of 
observations in each category, or because they perfectly predict SAH (e.g., all patients with 
SAH was admitted for treatment, so the admission variable perfectly predicted who had SAH 
and cannot be included in the regression model.).  From this result, we created two clinical 
decision rules for SAH prediction, Rule 1 with 5 components as listed in Table H (age more 
than 50 years old, onset during exertion, “worst headache of my life,” peak in less than 1 
second, associated with neck pain or stiffness), and Rule 2 with 4 components without the 
“worst headache of my life” component.   
 
Lastly, we applied our rules and compared the result to Ottawa SAH rule.  Table H 
lists the screening result using each rule.  Because we did not perform a physical exam in our 
study and did not have the criteria “limited neck flexion on physical exam” as one of the 
extended Ottawa SAH rule criteria, we only included the original Ottawa and (Ottawa + 
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presence of a thunderclap headache, defined here as peaking within 1 minute).  All four rules 
reach a sensitivity of 100%.  The specificities of Rule 1, Rule 2, Ottawa, and Ottawa + TCH 
are 0.7%, 37.0%, 23.9%, and 20.3%, respectively.  All four rules have a negative predictive 
value of 100% and a negative likelihood ratio of 0. 
 
Table H - Clinical Rules Derived from Our Study 
Rule 1 Rule 2 
• Age ≥ 50 
• Onset during exertion 
• Peak in <1 second 
• Neck pain/stiffness 
• “Worst headache of my life” 
• Age ≥ 50 
• Onset during exertion 
• Peak in <1 second 
• Neck pain/stiffness 
 
 
Table I - Comparison of our clinical decision rule with Ottawa SAH rule 
Result assessment Rule 1 Rule 2 Ottawa Ottawa (+TCH) 
Positive, No.     
   SAH 20 20 20 20 
   No SAH 137 87 105 110 
Negative, No.     
   SAH 0 0 0 0 
   No SAH 1 51 33 28 
Sensitivity 100.0% 100.0% 100.0% 100.0% 
Specificity 0.7% 37.0% 23.9% 20.3% 
Negative Predictive Value 100.0% 100.0% 100% 100% 
Likelihood ratio (95% CI)     
   Positive 1.01 1.59 1.31 1.25 
   Negative 0.00 0.00 0.00 0.00 
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Discussion 
Our findings suggest that adult patients presenting to the emergency department with 
any of the following characteristics and should be considered to be at higher-risk for SAH: 
older than 50 years old, headache onset during exertion, the worst headache ever experienced, 
and associated with neck pain or stiffness.  Of note, even though we reported statistically 
significant odd ratios for these variables and controlled for confounding factors, the 
confidence intervals remain large, most likely secondary to our small sample size.     
 
Similar to age trends seen in the published literature, SAH is more often seen in 
adults more than 50 years old [36].  Existing clinical decision rules, including the Ottawa 
SAH Rule and the EMERALD SAH rule, both use 40 years old as the cut-off.  However, the 
result from our study was only robust with a cut off of 50 years old.  This can also be better 
applied in the resource-poor setting.  In developing countries, especially those who have 
gone through large wars like Vietnam, the majority of the population is younger.  Thus, 
having an older cut off age, when appropriate, would help decrease the burden on the already 
over-taxed healthcare system.  As a result, we used 50-years-old as one of our criteria. 
 
Except for the addition of “worst headache of my life” to our rule, the other four 
criteria are similar to the Ottawa SAH rule. When we excluded this variable from our clinical 
decision rule (Rule 2), the sensitivity stayed the same at 100%, and the specificity improved 
from 0.7% to 37%.  Rule 2’s specificity was also higher than those from Ottawa SAH rules 
(23.9% and 20.3%).  Further validation study is needed to tease out if the rule’s sensitivity 
and specificity truly hold up. We also found that the onset of headache in SAH was 
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instantaneous – defined clearly as time to peak onset of less than 1 second – instead of the 
other variety of “thunderclap headache” definitions.  The trend observed here suggests that 
SAH headache has very rapid onset compared to other more benign causes of headache, such 
as cluster headaches which generally peak in 15 minutes or less, migraines which peak in 20 
minutes to 2 hours, and tension-type headaches which peak in 4 to 6 hours [52].   
 
Loss of consciousness or confusion was not found to be statistically significant before 
or after adjustments.  This is different from previous literature where 40.4% of patients 
reported LOC at the onset of SAH, and was thought to be an important manifestation of early 
brain injury [7, 53-55].  It was also a component of the existing Ottawa and EMERALD SAH 
rules [36, 38].  The difference observed in our data and analysis may be due to the 
broadening of the patient population, or may be because of differences in the definition of 
loss of consciousness. In our study, we defined it as “passing out” per the patients, with or 
without a witness. Given our result, it was excluded from our rules.  This exclusion of loss of 
consciousness and introduction of “worst headache of my life” as a variable did not 
significantly affect the sensitivity (100%), negative predictive value (100%), or the negative 
likelihood ratio (0.0) of our rules compared to the existing Ottawa SAH rule. Especially with 
the high sensitivity and low negative likelihood ratio, we can conclude that the likelihood of 
SAH is low in the absence of all 5 criteria. 
 
With relaxing our inclusion criteria compared to existing clinical decision rules 
(Ottawa SAH rule, EMERALD SAH rule, etc.), we are studying a broader population, which 
also dilutes the prevalence and risk of SAH in our study populations.  This can dilute the 
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target disorder in the sample, increasing generalizability but reducing precision and risking 
low utility if pretest probabilities are too low (making workups futile) [37].  Doing so can 
also make the research prohibitively expensive because we have to test a larger population to 
get enough SAH patients and maintain the same power for data analysis.  We were aware of 
this trade-off when we started the project.  Given our main purpose of applying these 
decision rules to even resource-poor settings as in the case of Vietnam to decrease triaging 
burden on existing resources, our focus was on increasing generalizability.  We have 
achieved some initial results with our data, which should be expanded to a larger scale and 
externally validated using a different patient population. 
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Limitations 
We acknowledge some potential limitations to this study.  The exclusion criteria 
prevented non-English speakers from being enrolled, most of whom were Spanish speakers 
who were Hispanic or Latino.  This prevented us from investigating SAH in Hispanic 
patients, who have been reported previously to have higher incidence of SAH [21].  This may 
have introduced a potential selection bias, which we tried to control for in our model using 
patient-disclosed ethnicity. 
 
Another limitation was the small size of our SAH patient population, which restricted 
the power of our statistical analyses, widened our confidence intervals, increased variability 
in our estimated ORs, and increased the risk of overfitting in our model.  Overfitting occurs 
when too many independent variables allow the researcher to find a relationship when in fact 
none exists.  If overfitting occurred, it increases Type I error.  As a rule of thumb, there 
should be at least 10 to 20 outcome events per independent variable of importance for 
statistical tests to be valid.  Overfitting leads to large CIs for each outcome measurement, 
which we did notice with some variables (e.g., “Worst headache of my life” variable and 
headache onset during exertion variable).  Since we had 158 observations, we kept the 
number of variables included in our model to 7 variables to prevent overfitting and decreased 
Type I error. 
 
Even though our clinical decision rules have 100% sensitivity, 100% negative 
predictive value, and a negative likelihood ratio of 0, which makes them great for ruling out 
SAH, they have low specificities, which may reduce its potential impact on practice. Our tool 
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also has only been internally validated using our data and not been validated in other patient 
populations yet. 
 
Implications and future directions 
A thorough history of headache characteristics should always be obtained for all 
patients presenting to the emergency department with a headache.  Based on our findings, 
patients meeting any of the following criteria should be considered at high-risk for SAH and 
considered for further work up with serum testing, imaging, and/or CSF analysis when 
appropriate:  
• Patients older than 50 years 
• Headache reached peak intensity instantaneously or in less than 1 second 
• Headache onset during exertion (exercise, sexual intercourse) 
• Worst headache ever 
• Associated with neck pain or neck stiffness. 
 
Our study was only an observational study done at a single center.  A larger study 
should be done in the future at multiple centers to externally validate our clinical rules 
obtained here, as well as to increase the power and generalizability of our results. 
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Appendix 2 – All headache characteristics of enrolled participants 
Table J – Demographic, presentation, and headache characteristics of enrolled participants 
(n=158) 
Characteristics Patients 
Age - Mean (SD) (range) 43 (17) (18-85) 
Age > 40 years old 84 53% 
Female sex  117 74% 
Hispanic 33 21% 
Caucasian 60 38% 
Admitted 35 22% 
Onset during exertion 22 14% 
Headache awoke patient from sleep 12 8% 
“Worst headache of my life” 21 13% 
Blood pressure on presentation - Mean (SD) (range)   
   SBP 135 (22) (99-209) 
   DBP 81 (15) (47-135) 
Time since onset   
   ≤ 60 minutes 4 3% 
   ~24 hours 31 20% 
   ~7 days 23 15% 
   >1 week  98 63% 
Location of pain (choose all that applies)   
   Temporal 23 15% 
   Occipital 42 27% 
   Parietal 13 8% 
   Frontal 46 29% 
   Holocranial 45 28% 
   Eye 21 13% 
   Ear 2 1% 
   Neck 6 4% 
   Jaw 1 1% 
   Other 15 9% 
Side of pain    
   Right 22 14% 
   Left 27 17% 
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Table J – Demographic, presentation, and headache characteristics of enrolled participants 
(n=158) 
Characteristics Patients 
   Both 102 65% 
   Varies 7 4% 
Size of headache > 6cm 128 81% 
Headache quality   
   Throbbing 74 47% 
   Pressure 74 47% 
   Achy 18 11% 
   Burning 6 4% 
   Tight 5 3% 
   Searing 2 1% 
   Dull 7 4% 
   Shooting 12 8% 
   Stabbing 14 9% 
   Other 29 18% 
Severity of headache (scale 0-10) Mean (SD) (Range)   
   Maximum pain 8.7 (1.7) (3-10) 
   Minimum pain 5.8 (3.3) (0-10) 
   Change in pain intensity = (Max-Min) 2.8 (3.0) (0-10) 
Severity based on Level of Disability   
   Normal activity 11 7% 
   Slight decrease in function 27 17% 
   Moderate decrease in function 40 25% 
   Severe decrease in function 45 28% 
   Confined to bed 33 21% 
Duration of headache   
   ≤60 minutes 4 3% 
   ~24 hours 31 20% 
   ~7 days 23 15% 
   >1 week 98 63% 
Presence of prior headaches 124 79% 
# of days of headache in past 1 month - Mean (SD) (range) 9 (10.5) (0-30) 
“Sentinel headache” in last 2 weeks 9 17% 
Thunderclap headache (peak < 1 minute) 39 25% 
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Table J – Demographic, presentation, and headache characteristics of enrolled participants 
(n=158) 
Characteristics Patients 
Time to peak onset   
   Instantly (<1 second) 27 17% 
   Less than 5 seconds 4 3% 
   5-10 seconds 5 3% 
   10 seconds – 1 minute 3 2% 
   1-2 minutes 2 1% 
   2-10 minutes 19 12% 
   10-30 minutes 9 6% 
   >30 minutes 88 56% 
Associated symptoms   
   Nausea 89 56% 
   Vomiting 37 23% 
   Photophobia 93 59% 
   Phonophobia 56 35% 
   Osmophobia 14 9% 
   Fever 17 11% 
   Polyuria 14 9% 
   Meningismus 74 47% 
   Tinnitus 25 16% 
   Blurry vision 65 41% 
   Anxiety 43 27% 
   Irritability 31 20% 
   Loss of consciousness 13 8% 
   Memory problem 18 11% 
   Confusion 28 18% 
   Teary eye (right) 7 4% 
   Teary eye (left) 3 2% 
   Teary eye (both) 32 20% 
   Nasal congestion (right) 5 3% 
   Nasal congestion (left) 1 1% 
   Nasal congestion (both) 24 15% 
   Red eye (right) 1 1% 
   Red eye (left) 1 1% 
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Table J – Demographic, presentation, and headache characteristics of enrolled participants 
(n=158) 
Characteristics Patients 
   Red eye (both) 11 7% 
   Ptosis (right) 2 1% 
   Ptosis (left) 1 1% 
   Ptosis (both 1 1% 
   Other 75 48% 
Preceding symptoms 14 9% 
   One-sided weakness 0 0% 
   General weakness 5 3% 
   Speech difficulty 0 0% 
   Double vision 1 1% 
   Lightheadedness 8 5% 
   Numbness/tingling 3 2% 
   Loss of vision in one eye 0 0% 
   Loss of vision on one side 0 0% 
   Vertigo 3 2% 
Provoking factors 52 33% 
   Food/Drinks   
   Fasting 5 3% 
   Chocolate 3 2% 
   Nitrates 0 0% 
   Alcohol beverages 4 3% 
   Physical exertion   
   Coughing 5 3% 
   Exercise 5 3% 
   Sexual intercourse 1 1% 
   Any exertion 22 14% 
   Medications   
   Anti-depressants 0 0% 
   Illicit drugs 0 0% 
   Migraine medications 0 0% 
   Other triggers 38 24% 
Activity that worsens headache   
   Lying down 25 16% 
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Table J – Demographic, presentation, and headache characteristics of enrolled participants 
(n=158) 
Characteristics Patients 
   Standing up 30 19% 
   Exercise 25 16% 
   Any activity 79 50% 
   Other 42 27% 
Relieving factors   
   Lying down 45 28% 
   Standing 2 1% 
   Hot compress 1 1% 
   Cold compress 18 11% 
   Dark quiet room 54 34% 
   Keeping active/Pacing 2 1% 
   Other 46 29% 
Past medical problems   
   Diabetes 14 9% 
   Hypertension 51 32% 
   Heart disease 8 5% 
   Stroke/TIA 4 3% 
   Seizures/Epilepsy 6 4% 
   Head injury 2 1% 
   Ear, nose, and throat problems 5 3% 
   Dental problems 1 1% 
   Cervical neck / spine problems 11 7% 
   Cancer 9 6% 
   Kidney/renal disease 9 6% 
   Brain hemorrhage 2 1% 
   Other 81 51% 
 
 
